Cerebrovascular accidents in giant cell arteritis: prevalence and predictive factors from the ARTESER registry

被引:0
|
作者
Martin-Gutierrez, Adrian [1 ]
Molina-Collada, Juan [2 ]
Dominguez-alvaro, Marta [3 ]
Melero-Gonzalez, Rafael B. [4 ]
Fernandez-Fernande, Elisa [5 ]
Silva-Diaz, Maite [6 ]
Valero, Jesus Alejandro [7 ]
Gonzalez, Ismael [8 ]
Martin, Julio Sanchez [1 ]
Narvaez, Javier [9 ]
Calvo, Itziar [10 ]
Aldasoro, Vicente [11 ]
Alcazar, Lydia Abasolo [12 ]
Loricera, Javier [1 ]
Ruiz-Roman, Alberto [13 ]
Castaneda, Santos [14 ]
Molina-Almela, Clara [15 ]
Villar, Maria Alcalde [16 ]
Mas, Antonio Juan [17 ]
Blanco, Ricardo [1 ]
ARTESER Project Collaborat Grp, Clara Moriano
机构
[1] Hosp Univ Marques Valdecilla, Rheumatol, IDIVAL, Immunopathol Grp, Santander, Spain
[2] Hosp Gen Univ Gregorio Maranon, Dept Rheumatol, Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain
[3] Soc Espanola Reumatol, Res Unit, Madrid, Spain
[4] Complexo Hosp Univ Ourense, Rheumatol Dept, Orense, Spain
[5] Hosp Univ La Paz, Rheumatol Dept, Madrid, Spain
[6] Complejo Hosp Univ Coruna, Rheumatol Dept, La Coruna, Spain
[7] Hosp Univ Donosti, Rheumatol Dept, Donosti, Spain
[8] Hosp Univ Leon, Rheumatol Dept, Leon, Spain
[9] Hosp Univ Bellvitge Hosp Llobregat, Rheumatol Dept, Barcelona, Spain
[10] Hosp Univ Basurto, Rheumatol Dept, Bilbao, Spain
[11] Complejo Hosp Navarra, Rheumatol Dept, Pamplona, Spain
[12] Hosp Clin San Carlos, Rheumatol Dept, IdISSC, Madrid, Spain
[13] Hosp Univ Virgen Rocio, Rheumatol Dept, Seville, Spain
[14] Univ Autonoma Madrid, Hosp Univ Princesa, Rheumatol Dept, IIS Princesa, Madrid, Spain
[15] Consorcio Hosp Gen Univ Valencia, Rheumatol, Valencia, Spain
[16] Hosp Univ Severo Ochoa Leganes, Rheumatol Dept, Madrid, Spain
[17] Hosp Univ Son Llatzer, Rheumatol Dept, Palma de Mallorca, Spain
关键词
cerebrovascular accidents; stroke; giant cell arteritis; vasculitis; predictive factors; cardiovascular disease; transient ischaemic attacks; CRANIAL ISCHEMIC COMPLICATIONS; AMERICAN-COLLEGE; RISK-FACTORS; VISUAL-LOSS; DISEASE; CLASSIFICATION; DIAGNOSIS; CRITERIA; EVENTS; STROKE;
D O I
10.1093/rheumatology/keaf051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the prevalence and predictive factors of cerebrovascular accidents (CVA) in GCA. Methods: ARTESER is a large Spanish multicentre registry including patients with GCA from across the entire country diagnosed between June 2013 and March 2019 and sponsored by the Spanish Society of Rheumatology. The variables collected at diagnosis were demographics, clinical manifestations (including the occurrence and location of CVA), laboratory, histology and imaging findings. Patients with and without CVA were compared in a bivariate analysis. Multivariate logistic regression was performed to determine potential predictive factors of CVA. Results: A total of 1540 patients with GCA were included for analysis (mean age 77.1 years, 70% females). CVA occurred in 61 (3.96%), of whom 38 (62.3%) involved the vertebrobasilar territory and 21 (34.4%) the carotid territory. The factors associated with CVA were the occurrence of transient ischaemic attack (TIA) [odds ratio (OR) 8.63; 95% CI 2.877-25.86], large vessel (LV) involvement (OR 2.79; 95% CI 1.421-5.465) and the presence of concomitant visual manifestations (OR 2.73; 95% CI 1.427-5.235). The risk of death during follow-up was significantly higher in patients with CVA (18% vs 8.8%; P = 0.014). Patients with CVA received significantly higher mean prednisone (mg) dose at diagnosis (433.9 vs 216; P < 0.001) and cumulative prednisone dose during follow-up (11 203.9 vs 8,194.1; P < 0.001). Conclusion: The prevalence of CVA in patients with GCA is low, but increases the risk of mortality. The presence of TIA, LV involvement and visual manifestations are factors associated with increased risk of CVA.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Risk Factors and Pharmacological Interventions Impacting Cerebrovascular Ischemic Events in Giant Cell Arteritis: A Narrative Review
    Siddiqui, Muhammad Osama
    Syed, Mohammad Ali
    Qureshi, Ayaan Ahmed
    Imam, Mustafa Hussain
    Motwani, Jatin
    Kumari, Verkha
    Siddiqui, Arooba
    Ul Ain, Noor
    Jaber, Mohammed Hammad
    IMMUNITY INFLAMMATION AND DISEASE, 2025, 13 (01)
  • [22] Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015
    Crowson, Cynthia S.
    Matteson, Eric L.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 47 (02) : 253 - 256
  • [23] Risk Factors for Permanent Visual Loss in Biopsy-proven Giant Cell Arteritis: A Study of 339 Patients
    Liozon, Eric
    Dalmay, Francois
    Lalloue, Fabrice
    Gondran, Guillaume
    Bezanahary, Holy
    Fauchais, Anne-Laure
    Ly, Kim-Heang
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (07) : 1393 - 1399
  • [24] Prevalence and prognostic factors for aortic dilatation in giant cell arteritis-a longitudinal study
    Jud, Philipp
    Verheyen, Nicolas
    Dejaco, Christian
    Haas, Elke
    Szolar, Dieter
    Meinitzer, Andreas
    Duftner, Christina
    Thonhofer, Rene
    Gressenberger, Paul
    Brodmann, Marianne
    Hafner, Franz
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2021, 51 (04) : 911 - 918
  • [25] Giant cell arteritis: insights from a monocentric retrospective cohort study
    Alnaimat, Fatima
    Alduradi, Hamza
    Al-Qasem, Soud
    Ghazzal, Hamza
    Alsarhan, Moath
    RHEUMATOLOGY INTERNATIONAL, 2024, 44 (06) : 1013 - 1023
  • [26] A Retrospective Study of Chinese Patients With Giant Cell Arteritis (GCA) Clinical Features and Factors Associated With Severe Ischemic Manifestations
    Sun, Fei
    Ma, Sha
    Zheng, Wenjie
    Tian, Xinping
    Zeng, Xiaofeng
    MEDICINE, 2016, 95 (13) : e3213
  • [27] Cardiovascular risk factors associated with polymyalgia rheumatica and giant cell arteritis in a prospective cohort: EPIC-Norfolk Study
    Yates, Max
    Luben, Robert
    Hayat, Shabina
    Mackie, Sarah L.
    Watts, Richard A.
    Khaw, Kay-Tee
    Wareham, Nick J.
    MacGregor, Alex J.
    RHEUMATOLOGY, 2020, 59 (02) : 319 - 323
  • [28] Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis
    Tsalapaki, Christina
    Lazarini, Argyro
    Argyriou, Evaggelia
    Dania, Vassiliki
    Boki, Kyriaki
    Evangelatos, Gerasimos
    Iliopoulos, Alexios
    Pappa, Maria
    Sfikakis, Petros P.
    Tektonidou, Maria G.
    Georgountzos, Athanasios
    Kaltsonoudis, Euripidis
    Voulgari, Paraskevi
    Drosos, Alexandros A.
    Theotikos, Evaggelos
    Papagoras, Charalampos
    Dimitroulas, Theodoros
    Garyfallos, Alexandros
    Kataxaki, Evaggelia
    Vosvotekas, Georgios
    Boumpas, Dimitrios
    Hadziyannis, Emilia
    Vassilopoulos, Dimitrios
    RHEUMATOLOGY INTERNATIONAL, 2024, 44 (04) : 603 - 610
  • [29] Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica
    De Miguel, Eugenio
    Macchioni, Pierluigi
    Conticini, Edoardo
    Campochiaro, Corrado
    Karalilova, Rositsa
    Monti, Sara
    Ponte, Cristina
    Klinowski, Giulia
    Monjo-Henry, Irene
    Falsetti, Paolo
    Batalov, Zguro
    Tomelleri, Alessandro
    Hocevar, Alojzija
    RHEUMATOLOGY, 2024, 63 (01) : 158 - 164
  • [30] Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink
    Li, Lin
    Neogi, Tuhina
    Jick, Susan
    RHEUMATOLOGY, 2017, 56 (05) : 753 - 762